Navigation Links
SUPERaseIn from Ambion
Tissue Stat from Biomeda Corporation
... proto-oncogene was first identified as the cellul...ne. Jun B and Jun D have been shown to be almost i...ch are involved in dimerization and DNA binding, w...d in transcriptional activation, diverge. Antig...
Mouse Anti-Yersinia pestis Capsular F1 Antigen Monoclonal Antibody, Unconjugated, Clone YBF19 from QED Bioscience Inc.
Rabbit Anti-JMJD2D Polyclonal Antibody, Unconjugated from Abcam
Biology Products:
(Date:12/3/2009)... , , WALL, N.J., Dec. 3 /PRNewswire-Fir...in Board: BKYI), a leader in wireless public safet...ons, announced that a majority of its shareholders...ved the sale of the company,s Law Enforcement Divi...res voted, 98.6% were cast in favor and 1.2% were ...
(Date:12/3/2009)... , A coating on windows or solar panels that re...cities for the next electric car? New Tel Aviv Uni...chnology , details a breakthrough in assembling pe...se futuristic visions come true in just a few year...oughly one-billionth of a meter) and even smaller,...
(Date:12/3/2009)... , Grand Rapids, Mich. (Dec. 3, 2009) Van Ande...mined precisely how the plant hormone abscisic aci...s respond to environmental stresses such as drough...nal Nature , could help engineer crops that thriv...t global food shortages. The findings could also ...
Breaking Biology News(10 mins):BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Lab Study Makes Strides in Mending Hearts 59283 1Lab Study Makes Strides in Mending Hearts 59283 2Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 1Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 2Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 3Proteolix Inc to be Acquired By Onyx Pharmaceuticals 59278 4Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 1Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 2Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 3Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 4Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 5Raptor Pharmaceutical Reports Positive Interim Phase 2a Clinical Data in Non Alcoholic Steatohepatitis 28NASH 29 14428 6
...ation for Molecular Pathology (AMP) announced toda...ties Union (ACLU) and the Public Patent Foundation...uman genes associated with breast and ovarian canc... Individuals with certain mutations along these tw...icantly higher risk for developing hereditary brea...
...pions cutting-edge medical research, a biomedical ... developing a new treatment for infants born with ...o prematurely fuse together. , The new approach i...s biodegradable and bio-absorbable. If successful,...s problematic bone fractures in adults, such as th...
... , Researchers of the University of Granada h... driven look up table based simulator,), which per...ystem, such as the retina, the cerebellum, the hea...ic advance permits to analyze and understand the f...to new pathologies and diseases or test new medici...
Other Biology News:Association for Molecular Pathology joins ACLU to challenge gene patents 2UC Davis bioengineer receives Hartwell Foundation grant to address skull fusion disorder of infants 2Development of an artificial simulator of the nervous system to do research into diseases 2
(Date:12/4/2009)...Iowa, Dec. 4 Vivakor, In... its shareholders of record on December 1, 2009 wi...of HealthAmerica, Inc. that was previously approve...is a private Nevada corporation of which Vivakor o...hares on the record date. The distribution date is...
(Date:12/4/2009)...f., Dec. 4 BlueFire Etha...any focused on changing the world,s transportation...rom non-food cellulosic wastes, has been ranked nu...ottest Companies in Bioenergy;" the company,s seco...voters rank BlueFire Ethanol among the top 20 bioe...
(Date:12/3/2009)...Dec. 3 ACCESS PHARMACE...y provided an update on its European commercial la... mucositis, a debilitating side effect of radiatio...ly launched by Access, partner, SpePharm, in six E...y, Norway, Greece and Sweden. Access is conducting...
(Date:12/3/2009)...lif., Dec. 3 Peregrine P...ced that it will release its financial results for...r 10, 2009 at 7:00 a.m. EST and will host a confer...:30 a.m. EST on the same day. ,, Peregrine,s se... the second quarter ended October 31, 2009 and wil...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 2BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 3BlueFire Named One of Top 20 Bioenergy Companies for Second Consecutive Year 4Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2